Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6521104 | 0.87 | ALDH1A1 (0.39) | ATMHCAR2SMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL6521048 | 0.85 | HCAR2 (0.45) | HCAR2SMN1; SMN2RAB9ANPSR1ALDH1A1 | |
| SCHEMBL6515419 | 0.85 | CES2 (0.39) | ATMSMN1; SMN2RAB9AALDH1A1LMNA | |
| SCHEMBL6523073 | 0.84 | ALDH1A1 (0.39) | ATMHCAR2SMN1; SMN2RAB9AALDH1A1 | |
| SCHEMBL6520377 | 0.82 | ATM (0.59) | ATMHCAR2SMN1; SMN2RAB9ANPSR1 | |
| SCHEMBL6519440 | 0.81 | ATM (0.50) | ATMHCAR2RAB9ANPSR1ALDH1A1 | |
| SCHEMBL6519734 | 0.81 | HCAR2 (0.47) | ATMHCAR2ALDH1A1LMNATHRB | |
| SCHEMBL6520745 | 0.79 | NAAA (0.39) | ATMHCAR2SMN1; SMN2RAB9ANPSR1 | |
| SCHEMBL6523452 | 0.78 | EPHX1 (0.34) | SMN1; SMN2RAB9ANPSR1ALDH1A1LMNA | |
| SCHEMBL5974049 | 0.77 | ATM (0.56) | ATMHCAR2SMN1; SMN2RAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ATM 4559/4885HCAR2 3143/4885SMN1; SMN2 1768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.